Trials / Completed
CompletedNCT04516213
Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG)
An Open-label, Single-arm Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG) in the Nutritional Management of Tube-fed Children Aged 1-4 Years.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 1 Year – 4 Years
- Healthy volunteers
- Not accepted
Summary
This is a Multicenter, Open-label, Single-arm study evaluating the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG) in the Nutritional Management of Tube-fed Children Aged 1-4 Years over a 7 day period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Enteral Formula With (PHGG) | Pediatric subjects will be fed a Peptide-based Enteral Formula With Partially Hydrolyzed Guar Gum (PHGG) |
Timeline
- Start date
- 2020-02-28
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2020-08-18
- Last updated
- 2024-10-15
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04516213. Inclusion in this directory is not an endorsement.